v3.26.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Mar. 31, 2024 [1] $ (25) $ 264,785 $ (239,697) $ (15) $ 2,138 $ 27,186
Balance, shares at Mar. 31, 2024 [1] 2,295,042            
Issuance of common stock – At The Market equity offering [1] 2,151 2,151
Issuance of common stock - At The Market equity offering, shares [1] 337,101            
Sale of common stock and pre-funded warrants [1] 18,858 18,858
Sale of common stock and pre-funded warrants, shares [1] 1,250,000            
Issue of common stock warrants [1] 3,159 3,159
Issuance of common stock upon exercise of warrants [1] 365 365
Issuance of common stock upon exercise of warrants, shares [1] 234,156            
Issuance of common stock upon vesting of restricted shares [1]
Issuance of common stock upon vesting of restricted shares, shares [1] 12,240            
NeuroNos issuance of stock [1] 1,765 235 2,000
Stock-based compensation [1] 8,907 239 9,146
Other comprehensive gain [1] (45) (45)
Net loss [1] (46,625) (1,854) (48,479)
Balance at Mar. 31, 2025 [1] (25) 299,990 (286,322) (60) 758 14,341
Balance, shares at Mar. 31, 2025 [1] 4,128,539            
Issuance of common stock – At The Market equity offering $ 1 [1] 8,134 8,135
Issuance of common stock - At The Market equity offering, shares [1] 2,441,775            
Sale of common stock and pre-funded warrants [1] 4,500 4,500
Sale of common stock and pre-funded warrants, shares [1] 524,990            
Issue of common stock warrants [1] 1,183 1,183
Issuance of common stock upon exercise of warrants [1] 2,868 2,868
Issuance of common stock upon exercise of warrants, shares [1] 3,088,704            
Issuance of common stock upon vesting of restricted shares [1]
Issuance of common stock upon vesting of restricted shares, shares [1] 8,630            
NeuroNos issuance of stock [1] 573 127 700
Stock-based compensation [1] 4,998 284 5,282
Other comprehensive gain [1] 194 194
Net loss [1] (33,249) (1,085) (34,334)
Issuance of common stock – 2025 Reverse Stock Split rounding [1]
Issuance of common stock - 2025 Reverse Stock Split rounding, shares             46
Issuance of common stock for conversion of debt [1] 3,341 $ 3,341
Issuance of common stock for conversion of debt, shares [1] 1,600,000            
Balance at Mar. 31, 2026 $ 1 [1] $ (25) $ 325,587 $ (319,571) $ 134 $ 84 $ 6,210
Balance, shares at Mar. 31, 2026 [1] 11,792,684            
[1] Prior period results have been adjusted to reflect the one-for-twenty stock split in July 2025. See Note 1, Organization and Business for details.